Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol and Valsartan FDC in Hypertension
NCT01508026Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Jan 2012
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nebivolol, valsartan in essential hypertension, sponsored by Forest Laboratories. Started Jan 2012; status: completed.
02
Drugs
nebivololvalsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01508026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01508026.